← Back to Search

Behavioural Intervention

Implementation Strategies for HPV Vaccination

N/A
Waitlist Available
Led By Daisy Y Morales Campos, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Implementation team members (i.e., administrative designee, health care providers, immunization navigators, and other staff), aged 18 and over, employed at each FQHC (4 members per practice)
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to understand how different factors in healthcare settings affect the success of strategies to improve HPV vaccination rates. It will test if these strategies, led by facilitators, can increase vaccine recommendations and administration

Who is the study for?
This trial is for healthcare providers and practices within Federally Qualified Health Centers aiming to improve HPV vaccination rates among Latino/a adolescents. Specific eligibility criteria are not detailed, but the focus is on provider behavior and practice-level strategies.
What is being tested?
The study tests if facilitator-driven strategies at both provider and practice levels can boost recommendations for HPV vaccinations and actual vaccination rates in nine different clinical sites.
What are the potential side effects?
Since this trial focuses on implementation strategies rather than medical treatments, it does not involve direct side effects like those associated with drugs or medical procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 and work at a health center as part of the vaccine team.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Step 3 (3 clinics)-27 months control then 18 months interventionExperimental Treatment1 Intervention
Group II: Step 2 (3 clinics)-21 months control then 24 months interventionExperimental Treatment1 Intervention
Group III: Step 1 (3 clinics)-15 months control then 30 months interventionExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,938 Previous Clinical Trials
41,021,046 Total Patients Enrolled
The University of Texas Health Science Center, HoustonLead Sponsor
957 Previous Clinical Trials
345,914 Total Patients Enrolled
Daisy Y Morales Campos, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
~1428 spots leftby Feb 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top